BridgeBio signs voluntary agreement with US government to expand Medicaid access to Attruby
BBIO•Voluntary agreement expands access to Attruby
BridgeBio entered a voluntary agreement with the U.S. government to expand access to its marketed medicine via the GENEROUS Model.
The deal targets broader Medicaid access and lower costs for uninsured patients.
The company expects no future pricing mandates under the agreement, and specific terms remain confidential.
Attruby will remain available through Medicare Part D without future pricing mandates.
BridgeBio said the ForgingBridges copay assistance program is unchanged and continues to support qualifying patients with out-of-pocket costs as low as $0 monthly.
